0001604902-18-000004.txt : 20181206 0001604902-18-000004.hdr.sgml : 20181206 20181206143121 ACCESSION NUMBER: 0001604902-18-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181206 DATE AS OF CHANGE: 20181206 EFFECTIVENESS DATE: 20181206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genomind, Inc. CENTRAL INDEX KEY: 0001604902 IRS NUMBER: 465193717 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-316836 FILM NUMBER: 181220271 BUSINESS ADDRESS: STREET 1: 100 HIGHPOINT DRIVE STREET 2: SUITE 102 CITY: CHALFONT STATE: PA ZIP: 18914 BUSINESS PHONE: (215) 396-5525 MAIL ADDRESS: STREET 1: 100 HIGHPOINT DRIVE STREET 2: SUITE 102 CITY: CHALFONT STATE: PA ZIP: 18914 D/A 1 primary_doc.xml X0708 D/A LIVE 0001604902 Genomind, Inc. 2200 Renaissance Boulevard Suite 100 King of Prussia PA PENNSYLVANIA 19406-2755 8778598658 DELAWARE None None Corporation true 2014 Ronald I. Dozoretz 240 Corporate Boulevard Norfolk VA VIRGINIA 23502 Executive Officer Director Promoter Shawn P. O'Brien 2200 Renaissance Boulevard Suite 100 King of Prussia PA PENNSYLVANIA 19406-2755 Executive Officer Director Beth E. Dozoretz 240 Corporate Boulevard Norfolk VA VIRGINIA 23502 Executive Officer Director Gloria Nuss 240 Corporate Boulevard Norfolk VA VIRGINIA 23502 Executive Officer Stephen Haller 240 Corporate Boulevard Norfolk VA VIRGINIA 23502 Executive Officer Thomas Hess 2200 Renaissance Boulevard Suite 100 King of Prussia PA PENNSYLVANIA 19406-2755 Executive Officer Joseph Anton 116 Huntington Avenue Boston MA MASSACHUSETTS 02116 Director Theresa Sexton 30 Burton Hills Boulevard Nashville TN TENNESSEE 37215 Director John Chadwick 30 Burton Hills Boulevard Nashville TN TENNESSEE 37215 Director Kip Olmstead 2200 Renaissance Boulevard Suite 100 King of Prussia PA PENNSYLVANIA 19406-2755 Executive Officer Other Health Care Decline to Disclose 06b true 0001604902-18-000003 2018-07-02 false true false 100000 4475000 4475000 0 false 2 0 0 0 false Genomind, Inc. Thomas Hess Thomas Hess Chief Financial Officer 2018-12-06